A recent study highlights the burden of illness and treatment dissatisfaction among patients with irritable bowel syndrome (IBS), particularly those with IBS with constipation (IBS-C) and IBS with diarrhea (IBS-D). The study found that abdominal pain and discomfort were key symptoms affecting daily activities and work productivity. Despite treatment efforts, many patients expressed dissatisfaction with their symptom control, though those using prescription medications reported better satisfaction compared to those relying solely on over-the-counter (OTC) treatments.
Survey participants were classified into IBS-C, IBS-D, or control cohorts using Rome IV criteria. Both IBS cohorts reported higher levels of anxiety, depression, and lower quality of life compared with controls. While most patients with IBS sought medical care, dissatisfaction with symptom control was prevalent, with prescription medications offering better outcomes than OTC treatments. The study also noted significant work productivity loss and daily activity impairment among patients with IBS. Researchers noted that future studies should focus on therapies that target abdominal pain and improve symptom control.
Reference: Brooks A. Patients with IBS Report Treatment Dissatisfaction, Lack of Symptom Control. Published September 10, 2024. Accessed September 19, 2024. https://www.hcplive.com/view/patients-with-ibs-report-treatment-dissatisfaction-lack-symptom-control
Link: https://www.hcplive.com/view/patients-with-ibs-report-treatment-dissatisfaction-lack-symptom-control
